Join The Waitlist!Want to be at the forefront of the emerging convergence between psychedelic medicine, technology, and consciousness?
TRIPP will soon be offering research-based protocols to safely support therapists and patients. Join the TRIPP PsyAssist waitlist and be the first to know when our protocols become available.
In recent years, psychedelics have moved from being categorized as illegal, Schedule I substances to groundbreaking treatments for mental health conditions like depression, anxiety, addiction, and post-traumatic stress disorder (PTSD).
Yet, even with ongoing clinical trials of psychedelic-assisted therapies and the clinical availability of ketamine to address mental health issues, patients need support with onboarding, pre-session anxiety reduction, and post-session integration, whether in-clinic or at home.
TRIPP PsyAssist will initially provide support for ketamine-assisted therapy. Our offering is designed to reduce patient anxiety before treatment and provide integration support post-treatment by combining TRIPP’s VR, AR, and mobile platforms, along with targeted protocols for psychedelic-assisted therapy.